Usefulness of the BTA test in the detection of bladder cancer;Die wertigkeit des BTA-tests zur erkennung des blasenkarzinoms

Aktuelle Urologie

Volumn 30, Issue 2, 1999, Pages 112-116

  Nunez C ^a   Martinez Pineiro L ^a   Madrid, F J ^a   Cisneros, J ^a   Viguer, J W ^a   Martinez Pineiro J A ^a   Mora, Carlos Nuñez ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b NONE   (Spain)

Author keywords

Bladder cancer; BTA; Cytology; Urinary sediment

Indexed keywords

EID: 0033095593     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-13302     Document Type: Article

References (15)

1. Graham, S. D., L. Watts: Comparison of MGH-1 and Tumark antibody detection in transitional cell carcinoma. J. Urol. 150 (1993) 1548-1550
2. Badalament, R. A., M. Kimmel, H. Gay, E. S. Cibas, W. F. Whitmore, H. W. Herr, W. R. Fair, M. R. Melamed: The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinoma. Cancer 59 (1987) 2078-2085
3. Schwalb, D. M., H. W. Her, W. R. Fair: The management of clinically unconfirmed positive urinary cytology. J. Urol. 150 (1993) 1751-1756
4. Badalament, R. A., H. Gay, E. S. Cibas, H. W. Herr, W. F. Whitmore, W. R. Fair, M. R. Melamed: Monitoring endoscopic treatment of superficial bladder carcinoma by postoperative urinary cytology. J. Urol. 138 (1987) 760-762
5. Harving, N., H. Wolf, F. Melsen: Positive urinary cytology after tumor resection: an indicator for concomitant carcinoma in situ. J. Urol. 140 (1988) 495-497
6. Takahashi, N., S. Takahashi, K. Takahashi, T. Suzuki, T. Funyu: A monocloncal antibody to human transitional cell carcinoma of the bladder: production and characterization. J. Urol. 138 (1987) 207-211
7. Huland, E., H. Huland, T. H. Meier, O. Baricordi, Y. Fradet, H. B. Grossman, G. M. Hodges, E. M. Messing, B. J. Schmitz-Draeger: Comparison of 16 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder. J. Urol. 146 (1991) 1631-1636
8. Conn, I. G., J. Crocket, D. M. A. Wallace, M. A. Hughes, C. J. Hilton: Basement membranes in urothelial carcinoma. Br. J. Urol. 60 (1987) 536-542
9. Sarosdy, M. F., R. W. de Vere White, M. S. Soloway, J. Sheinfeld, M. A. Hudson, P. F. Schellhammer, M. V. Jarowenko, G. Adams, B. A. Blumenstein: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J. Urol. 154 (1995) 379-384
10. American Joint Committe on Cancer: Staging of cancer at genitourinary sites. In: American Joint Committe on Cancer: Manual for Staging of Cancer, 3rd Edition. Philadelphia: J. B. Lippincott Co., (1988) pp.194-195
11. Mostofi, F. K.: Histological typing of urinary bladder tumours. Geneva: World Health Organization (1973)
12. D'Hallewin, M. A., L. Baert: Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J. Urol. 155 (1996) 475-476
13. Loening, S., A. Narayana, L. Yoder, D. Slymen, S. Weinstein, G. Penick, D. Culp: Factors influencing the recurrence rate of bladder cancer. J. Urol. 123 (1979) 29-31
14. Report from the BTA Key Evaluator Programme forum. Amsterdam, Juni 13, 1995.The Bard® BTA®test: its role in bladder cancer management. Uro. Communications, PO Box 162, 6590 AD, Gennep, The Netherlands.
15. Leyh, H., E. Mazeman, R. R. Hall, A. H. Bennet: Results of a European multicenter trial comparing the Bard BTA test to urine cytology in patients suspected of having bladder cancer. XIIth Congress of the European Association of Urology, September 1-4, 1996, Paris Abstract 859. Published in Eur. Urol. 30 (suppl. 2) (1996) 231